AN2 THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.27 USD | 0.00% |
|
-6.20% | -88.92% |
| 16/05 | Evercore ISI Adjusts Price Target on AN2 Therapeutics to $2 From $7, Maintains In-Line Rating | MT |
| 03/04 | North American Morning Briefing : Powell Awaited -2- | DJ |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 67.71M | - | - | - | - | - | |
| 50.85B | - | |||||
| 42.82B | ||||||
| 42.03B | ||||||
| 29.55B | ||||||
| 26.11B |
